Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · EXOZYMES INC. (EXOZ)

Exozymes sets 2026 annual meeting for November 13, 2026; proxy mailing around Sept. 28

Neutral Impact 1 of 5 shareholder Written later

Exozymes said it will hold its 2026 annual shareholder meeting on November 13, 2026. The company plans to send its proxy statement and proxy to shareholders on or about September 28, 2026, with a record date of September 15, 2026. The filing is administrative and contains no financial results or other business changes.

Key points

  • Annual meeting set for November 13, 2026
  • Proxy statement and proxy to be distributed on or about September 28, 2026
  • Record date for the meeting was September 15, 2026

The filing

CompanyEXOZYMES INC. (EXOZ)
Form8-K, current report
Filed with the SECSep 18, 2026, 1:24 PM ET
Accession number0001493152-26-043288

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 18, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.